Home › Funds › MIC Capital Management UK LLP › RXRX

MIC Capital Management UK LLP position in RXRX

RECURSION PHARMACEUTICALS IN · Health Care

MIC Capital Management UK LLP reported holding 8,255,144 shares of RXRX (RECURSION PHARMACEUTICALS IN) in its Q3 2026 13F filing — a position valued at US$34.1M, representing 7.36% of its reported portfolio and ranking #3 among its reported holdings. MIC Capital Management UK LLP has disclosed RXRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)8.26M sh
Reported value held$34.09M
Portfolio Weight7.36%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How MIC Capital Management UK LLP's RXRX position evolved

MIC Capital Management UK LLP first disclosed a stake in RXRX in Q3 2023 at 8,451,758 shares (US$64.7M). The position peaked in Q1 2024 at 8,451,758 shares, worth US$84.3M. Across 13 filings, MIC Capital Management UK LLP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 8,255,144 shares valued at US$34.1M — a reduction of -1,388,889 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 8.45M $64.66M New
Q4 2023 8.45M $83.33M Hold
Q1 2024 8.45M $84.26M Hold
Q2 2024 8.45M $63.39M Hold
Q3 2024 8.45M $55.70M Hold
Q4 2024 9.64M $65.19M Add
Q1 2025 9.64M $51.02M Hold
Q2 2025 9.64M $48.80M Hold
Q3 2025 9.64M $47.06M Hold
Q4 2025 9.64M $39.44M Hold
Q1 2026 9.64M $29.61M Hold
Q2 2026 9.64M $35.39M Hold
Q3 2026 8.26M $34.09M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RXRX and 13F data

RXRX (RECURSION PHARMACEUTICALS IN) is a Health Care company. 27 other funds we track also report a position in RXRX — the largest reported positions include ARK Invest (US$184.8M), SOFTBANK GROUP CORP. (US$50.0M), Data Collective IV GP, LLC (US$21.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RXRX

All RXRX fund holders →

FAQ

How long has MIC Capital Management UK LLP held RXRX?

MIC Capital Management UK LLP has disclosed RXRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is MIC Capital Management UK LLP's current position in RXRX?

As of Q3 2026, MIC Capital Management UK LLP holds 8.26M shares of RXRX (RECURSION PHARMACEUTICALS IN), valued at $34.09M, representing 7.36% of its reported portfolio and ranking #3.

Has MIC Capital Management UK LLP been buying or selling RXRX?

In the latest 13F filing (Q3 2026), MIC Capital Management UK LLP reduced its position in RXRX. The position peaked in Q1 2024 at 8.45M shares.

Which other funds hold RXRX?

Other major institutional holders of RXRX include ARK Invest, SOFTBANK GROUP CORP., Data Collective IV GP, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.